A New Treatment for Migraine
Thanks to the latest research, we can now target specific migraine pathways.
Infusions Explained
Infusion therapy may seem modern, but its origins trace as far back as 1492.
Dr. Weisman interviewed in Neurology Insights
Dr. Weisman has been interviewed in a new article in Neurology Insights regarding the unique challenges faced by Alzheimer’s patients and caregivers during the pandemic.
How ANA is keeping you safe
Your health is our top priority and we want to ensure that you are accessing — and not delaying — the care you need.
The Pandemic Will End: How and Why
In many ways we’ve been fortunate. Despite a pandemic, society has not broken down.
Epilepsy Patient Newsletter February 2020
The field of epilepsy has seen great strides in the last couple of decades.
Alzheimer’s Patient Newsletter February 2020
Aducanumab, the first Alzheimer’s-modifying therapy, submitted to the FDA. Can Biogen recover from their errors?
Dr. Weisman interviewed on Boomer Living podcast
“If you have a loved one with dementia, you know this can be a heart-wrenching process. You cannot change the person. . . . You have to meet them where they are, roll with it, and speak with love and patience. It was a pleasure to speak to Dr. David Weisman, a neurologist.”
MS Patient Newsletter December 2019
The field of MS research has had amazing success in the last two decades.
MS Physician Newsletter October 2019
Multiple sclerosis (MS) is an autoimmune disease in which the immune system misrecognizes part of the brain called myelin.